Compare BridgeBio Pharma Inc (BBIO) vs Select Medical Holdings Corporation (SEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Select Medical Holdings Corporation — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B). The key difference: BridgeBio Pharma Inc is far larger — about 7.9× Select Medical Holdings Corporation's market cap, and Select Medical Holdings Corporation pays a 1.51% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | SEM | |
|---|---|---|
Market Cap | $16.27B | $2.05B |
Sector | Health | Health |
52-Week High | $90.17 | $16.66 |
52-Week Low | $44.81 | $11.77 |
Enterprise Value | $17.82B | $5.01B |
Dividend Yield | — | 1.51% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Select Medical Holdings Corporation
Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.
Read more on SEM →
